Baxter International stock faces a Q3 EPS estimate cut
Published on 09/30/2026 at 14:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International stock (ISIN US0673431090) faces a Q3 2026 EPS estimate cut to USD 0.51 from USD 0.53, according to MarketBeat on September 28, 2026. The change keeps Zacks Research at a Hold rating and puts estimate discipline ahead of the companys recent earnings beat.
Q3 estimate moves to USD 0.51
MarketBeat reports that Zacks Research lowered its Q3 2026 EPS forecast from USD 0.53 to USD 0.51 while maintaining Hold. The USD 0.02 reduction is a concrete counterweight to the stronger second-quarter result and signals that near-term earnings expectations remain sensitive.
The same report places Baxter analysts at two Buy, nine Hold and two Sell ratings, with an average 12-month price target of USD 22.45. The rating mix gives the estimate reduction more weight than a single analysts view because it describes a broad consensus rather than one isolated target.
Q2 revenue beats by USD 0.16 billion
Baxters latest reported quarter delivered USD 0.56 EPS against USD 0.37 consensus, a USD 0.19 beat, while revenue reached USD 2.96 billion versus USD 2.80 billion expected, according to MarketBeat. The revenue result was 5.30 percent higher than the same quarter a year earlier.
MarketBeat says Baxter set FY2026 EPS guidance at USD 1.95-2.15. That range is the key bridge between the Q2 beat and the lower Q3 estimate because it defines the earnings level management still expects for the full fiscal year.
Market cap stands at USD 12.1 billion
Baxter had a market capitalization of USD 12.1 billion on September 30, 2026, with a 52-week range of USD 15.73-30.00. The company is listed on the NYSE under ticker BAX, and its healthcare equipment and supplies business serves hospitals and other care settings.
Investing.com lists October 29, 2026 as the next earnings date. Baxter describes its portfolio as spanning infusion and nutrition, pharmaceuticals, surgical technologies, respiratory therapy and connected care on its Baxter website.
Baxter International stock at a glance
- Company: Baxter International Inc.
- ISIN: US0673431090
- Ticker: BAX
- Primary exchange: NYSE
- Market capitalization: USD 12.1 billion (as of September 30, 2026)
- 52-week range: USD 15.73-30.00 (as of September 30, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Next earnings date: October 29, 2026
